After a breathing stage, the bullish trend should continue.

The company shows strong fundamentals, underlines by the excellent Surperformance rating. Sales and EBITDA are expected to keep their large 2 digits growth. The share has still a +5% potential to reach the consensus average price target. Moreover, the interim earnings release are expected around 23rd of April.

Technically, the stock has undergone a profit-taking near the USD 102 resistance, followed by a brief rebound and a correction that brang back the share close to the USD 93.04 pivot point. Moving averages are very well oriented and especially the 20 periods moving averages help supporting the security. In this configuration, investors can legitimately expect a reversal toward the USD 102 resistance and by extension the upper trend line. A stop loss should be set at USD 92.2.